EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A New Nanotechnology for Imaging the Juxta‐Articular Intraosseous Vasculature‐Canal Complex and Related Clinical Pilot Studies

Mengmeng Dou, Jinfeng Yang, Jiaoran Li, Jianmin Li, Zhenzhong Li, Xianhao Shao iD, Xia Su, Jing Li, Guanghui Wang, Kun Cheng

Orthopaedic Surgery · 2025

DOI: 10.1111/os.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Orthopaedic Surgery, 2025. Verfasst von Mengmeng Dou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tianjin First Central Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Contrast Media, Nanotechnology, Microvessels, Magnetic Iron Oxide Nanoparticles. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Natural Science Foundation of Shandong Province, Qingdao Clinical Key Specialty.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study is to achieve distinct visualization of juxta‐articular intraosseous microvessels, a novel nanoimaging methodology in which superparamagnetic iron oxide nanoparticles and meglumine diatrizoate (MD) are used cooperatively was implemented.

Methods

A newly created composite of MD and Fe 3 O 4 nanoparticles (MD‐Fe 3 O 4 NPs) was prepared as a contrast agent to achieve efficacious imaging of the juxta‐articular intraosseous vasculature‐canal complex (JIVCC). Scanning electron microscopy (SEM) and energy dispersive spectrum (EDS) were employed to observe the structural characteristics and binding stability of the MD‐Fe 3 O 4 NPs. In 20 rabbits that received an injection of MD‐Fe 3 O 4 NPs, 1‐mm‐thick computed tomography (CT) scanning was performed for radiographic assessment. Hematoxylin–eosin‐ and potassium ferrocyanide‐stained sections from 10 sacrificed rabbits were used to observe the histological characteristics of JIVCC with MD‐Fe 3 O 4 NPs, and the remaining 10 rabbits were utilized for a systemic safety evaluation. After a healthy volunteer received an MD‐Fe 3 O 4 NP injection, we also performed CT scanning and related safety evaluations.

Results

When the MD nanoparticles and amino‐Fe 3 O 4 nanoparticles were mixed together, they aggregated into a stable compound structure according to microscopic observations and SEM–EDS verification. In 20 rabbits receiving MD‐Fe 3 O 4 injections, 1‐mm slice CT imaging demonstrated significantly enhanced visualization of the JIVCCs in magnet‐placed knees compared to contralateral limbs (tibial JIVCC: p < 0.001; femoral JIVCC: p < 0.001), confirming MD‐Fe 3 O 4 NPs as the efficacious magnetic contrast enhancer. The histological characteristics of MD‐Fe 3 O 4 NPs in JIVCC were revealed. The levels of serum iron before and 4 and 72 h after MD‐Fe 3 O 4 NP injection were 23.9 ± 2.13 μmol/L, 26.2 ± 2.30 μmol/L, and 24.9 ± 2.33 μmol/L, respectively, indicating that there was no significant difference in safety ( p = 0.092). After a volunteer received MD‐Fe 3 O 4 NPs via intravenous administration, the JIVCC was clearly visualized, laboratory tests of serum iron levels were normal, and no injection‐related complications occurred.

Conclusions

A novel compound nanoparticle, which achieved satisfactory overall outcomes, was implemented as an appropriate alternative for the discernible visualization of juxta‐articular intraosseous microvessels. The nanotechnology utilized in this study may augment the clinical imaging methodology for the osseous vascular system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaNanotechnologyMicrovesselsMagnetic Iron Oxide NanoparticlesAnimalsRabbitsPilot ProjectsTomography, X-Ray ComputedHumansMagnetite NanoparticlesMicroscopy, Electron, Scanning

Stichwörter der Autor:innen

imagingintraosseous vasculaturemeglumine diatrizoatenanotechnologysuperparamagnetic iron oxide

Substanzen

Contrast MediaMagnetite Nanoparticles

Autor:innen und Institutionen

  • Department of Neurology, Tianjin First Central Hospital, Tianjin, China.
  • Department of Orthopaedics, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China.
  • Department of Equipment and Materials, Tianjin First Central Hospital, Tianjin, China.
  • Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, China.
  • Department of Orthopaedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Department of Anatomy and Neurobiology, Cheeloo College of Medicine, Shandong University, Jinan, China.

ORCID-Profile: Xianhao Shao

Förderung

  • the Natural Science Foundation of Shandong Province
  • Qingdao Clinical Key Specialty

Zitieren

APA

Dou, M., Yang, J., Li, J., Li, J., Li, Z., Shao, X., Su, X., Li, J., Wang, G., & Cheng, K. (2025). A New Nanotechnology for Imaging the Juxta‐Articular Intraosseous Vasculature‐Canal Complex and Related Clinical Pilot Studies. Orthopaedic Surgery. https://doi.org/10.1111/os.70149

Vancouver

Dou M, Yang J, Li J, Li J, Li Z, Shao X, et al. A New Nanotechnology for Imaging the Juxta‐Articular Intraosseous Vasculature‐Canal Complex and Related Clinical Pilot Studies. Orthopaedic Surgery. 2025. doi:10.1111/os.70149

BibTeX
@article{Dou2025,
  author = {Dou, Mengmeng and Yang, Jinfeng and Li, Jiaoran and Li, Jianmin and Li, Zhenzhong and Shao, Xianhao and Su, Xia and Li, Jing and Wang, Guanghui and Cheng, Kun},
  title = {A New Nanotechnology for Imaging the Juxta‐Articular Intraosseous Vasculature‐Canal Complex and Related Clinical Pilot Studies},
  journal = {Orthopaedic Surgery},
  year = {2025},
  doi = {10.1111/os.70149}
}
Kostenlos starten →